NAS:ALKS (Ireland)  
Alkermes PLC logo

Alkermes PLC

$ 22.33 -0.13 (-0.58%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
3.39
Market Cap:
$ 3.67B
Enterprise V:
$ 3.50B
Volume:
1.91M
Avg Vol (2M):
1.33M
Also Trade In:
Volume:
1.91M
Market Cap $:
3.67B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.33M
Enterprise Value $:
3.50B
PB Ratio:
3.39
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.
Name Current Vs Industry Vs History
Cash-To-Debt 1.42
Equity-to-Asset 0.55
Debt-to-Equity 0.38
Debt-to-EBITDA -25.85
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.18
Distress
Grey
Safe
Beneish M-Score -3.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.56
9-Day RSI 37.5
14-Day RSI 36.16
6-1 Month Momentum % -10.03
12-1 Month Momentum % -23.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.39
Quick Ratio 2.03
Cash Ratio 1.32
Days Inventory 86.27
Days Sales Outstanding 86.82
Days Payable 22.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.3

Financials (Next Earnings Date:2022-10-27 Est.)

ALKS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALKS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,173.368
EPS (TTM) ($) -0.57
Beta 0.28
Volatility % 37.34
14-Day RSI 36.16
14-Day ATR ($) 0.672582
20-Day SMA ($) 23.226
12-1 Month Momentum % -23.25
52-Week Range ($) 21.24 - 33
Shares Outstanding (Mil) 164.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alkermes PLC Filings

Document Form Filing Date
No Filing Data

Alkermes PLC Analysis

Share your research

Headlines

See More
No news.